Blade Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Blade Therapeutics, Inc. - overview
Established
2015
Location
South San Francisco, CA, US
Primary Industry
Biotechnology
About
Founded in 2015 and based in California, US, Blade Therapeutics, Inc. researches and develops novel therapies for fibrotic diseases in the liver, lung, kidney, and skin caused by increased levels of autotaxin/lysophosphatidic acid (LPA).
Current Investors
OUP (Osage University Partners), MPM BioImpact, Bristol-Myers Squibb Company
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.blademed.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.